Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
11.06
+1.15 (11.60%)
Oct 27, 2026, 1:46 PM EDT - Market open
Arcturus Therapeutics Holdings Employees
As of December 31, 2025, Arcturus Therapeutics Holdings had 111 total employees, including 106 full-time and 5 part-time employees. The number of employees decreased by 65 or 36.93% compared to the previous year. That makes Arcturus Therapeutics Holdings the 30,753rd largest employer in the world and 3,938th in the United States.
Employees
111
Change (1Y)
-65
Growth (1Y)
-36.93%
Revenue / Employee
$264,577
Profits / Employee
-$840,324
Market Cap
314.36M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 111 | -65 | -36.93% | 106 | 5 |
| Dec 31, 2024 | 176 | -4 | -2.22% | 174 | 2 |
| Dec 31, 2023 | 180 | 10 | 5.88% | 180 | 0 |
| Dec 31, 2022 | 170 | -7 | -3.95% | 170 | 0 |
| Dec 31, 2021 | 177 | 59 | 50.00% | 177 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Artiva Biotherapeutics | 115 |
| Alector | 103 |
| Scribe Therapeutics | 82 |
| Agenus | 81 |
| Contineum Therapeutics | 51 |
| Vicore Pharma Holding AB | 46 |
| Inhibikase Therapeutics | 35 |
| Opus Genetics | 28 |
ARCT News
- 21 hours ago - Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026 - Business Wire
- 4 weeks ago - Arcturus Therapeutics price target lowered to $20 from $23 at BTIG - TheFly
- 4 weeks ago - Arcturus Therapeutics upgraded to Buy from Neutral at Citi - TheFly
- 4 weeks ago - Arcturus Therapeutics upgraded to Buy from Neutral at Citi - TheFly
- 4 weeks ago - Arcturus Therapeutics Holdings Transcript: Status update - Transcripts
- 4 weeks ago - Arcturus Therapeutics Holdings Press release: Status update - Filings
- 4 weeks ago - Arcturus Therapeutics Holdings Slides: Status update - Filings
- 4 weeks ago - Arcturus Therapeutics announces interim OTC deficiency Phase 2 results - TheFly